- Home
- USLM vs AXSM Comparison
USLM vs AXSM Comparison
Compare USLM & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USLM
- AXSM
- Stock Information
- Founded
- USLM 1948
- AXSM 2012
- Country
- USLM United States
- AXSM United States
- Employees
- USLM N/A
- AXSM N/A
- Industry
- USLM Other Metals and Minerals
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- USLM Industrials
- AXSM Health Care
- Exchange
- USLM Nasdaq
- AXSM Nasdaq
- Market Cap
- USLM 4.3B
- AXSM 4.2B
- IPO Year
- USLM N/A
- AXSM 2015
- Fundamental
- Price
- USLM $118.98
- AXSM $96.18
- Analyst Decision
- USLM
- AXSM Strong Buy
- Analyst Count
- USLM 0
- AXSM 13
- Target Price
- USLM N/A
- AXSM $130.69
- AVG Volume (30 Days)
- USLM 109.9K
- AXSM 965.3K
- Earning Date
- USLM 01-31-2025
- AXSM 02-18-2025
- Dividend Yield
- USLM 0.17%
- AXSM N/A
- EPS Growth
- USLM 43.42
- AXSM N/A
- EPS
- USLM 3.44
- AXSM N/A
- Revenue
- USLM $303,351,000.00
- AXSM $338,457,000.00
- Revenue This Year
- USLM N/A
- AXSM $44.77
- Revenue Next Year
- USLM N/A
- AXSM $67.70
- P/E Ratio
- USLM $35.08
- AXSM N/A
- Revenue Growth
- USLM 10.74
- AXSM 51.47
- 52 Week Low
- USLM $45.74
- AXSM $64.11
- 52 Week High
- USLM $159.53
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- USLM 35.55
- AXSM 59.04
- Support Level
- USLM $116.03
- AXSM $91.81
- Resistance Level
- USLM $127.19
- AXSM $95.36
- Average True Range (ATR)
- USLM 5.37
- AXSM 4.95
- MACD
- USLM -0.34
- AXSM 1.43
- Stochastic Oscillator
- USLM 13.86
- AXSM 89.89
About USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime, and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.